The Hemp Industries Association (HIA), the leading non-profit trade associationconsisting of hundreds of hemp businesses, filed a Petition for Review on January 13, 2017, in the NinthCircuit Court of Appeals in San Francisco, seeking to block the implementation of the Drug EnforcementAdministration’s (DEA) recently announced Final Rule regarding “Marihuana Extract.” The proposed DEAFinal Rule attempts to unlawfully designate hemp-derived non-psychoactive cannabinoids, includingcannabidiol, as “marihuana extract,” and append the Controlled Substances Act to add all cannabinoids toits Schedule I. Furthermore, this action by the DEA contravenes clear Congressional intent and legalparameters for the production and consumption of hemp-derived products containing cannabinoids,enacted by Sec. 7606 of the Agricultural Act of 2014 (Farm Bill).
To read the full petition, please visit:
•
The DEA does not have the authority to augment the Controlled Substances Act; that power resides withCongress. Congress has clearly mandated, through the 2014 Farm Bill and the 2016 Omnibus Spending Lawthat the Controlled Substances Act does not apply to hemp grown in state pilot programs, and that it is aviolation of federal law for agencies such as DEA to interfere with these programs. The DEA’s proposed ruleregarding cannabinoids thumbs its nose at Congress and threatens to undermine the market for legal hempproducts containing cannabinoids, including those produced in the U.S. under state laws that regulate hempcultivation and processing pursuant to, and in accordance with the federal Farm Bill. These products, suchas hemp foods and supplements, fall outside the Controlled Substances Act (CSA) and are not subject toregulatory control by the DEA.
“Hemp-derived products containing cannabinoids are an increasingly in-demand category within the hempmarket—and U.S. consumers constitute the largest market for hemp products worldwide,” said ColleenKeahey, Executive Director of the Hemp Industries Association. “We are committed to defending the rightsof our members, of entrepreneurial hemp farmers, businesses and consumers, who all are acting entirelywithin the legal framework of the CSA and Farm Bill, including those adversely affected by trying to sourceAmerican-grown hemp and hemp derivatives to supply this demand. The DEA’s attempt to regulate hemp derivedproducts containing cannabinoids lawfully sourced under the CSA, and farmed and produced underthe Farm Bill in states like Kentucky and Colorado, is not only outside the scope of their power, it’s anattempt to rob us of hemp’s economic opportunity.”
The DEA has made previous attempts to interfere with legal hemp products, notably from 2001-2003 whenthe agency contended that hemp food products such as cereals, hemp seed and hemp oil, are a Schedule Isubstance due to trace insignificant residues of tetrahydrocannabinol, or THC. On February 6, 2004, theNinth Circuit Court of Appeals ruled in response that hemp is not included in Schedule I; that the trace THCin such products is similar to trace opiates in poppy seed bagels, and does not render them controlledsubstances. The HIA believes this 2004 ruling sets strong legal precedent for the current petition, whichasserts that cannabinoids derived from lawful portions and varieties of the Cannabis plant exempted fromcontrol under the CSA and through the Farm Bill, may not be regulated as “marihuana” or “marihuanaextract” by the DEA.
More recently, in 2014, the DEA interfered with the implementation of state pilot programs for hempfarming, when the agency unlawfully seized 250 lbs. of certified industrial hemp seed imported from Italy.The viable hemp seed had been legally sourced to supply six hemp research projects licensed by theKentucky Department of Agriculture and coordinated in conjunction with Kentucky State academicinstitutions. The seed was quickly released, following the filing of a lawsuit against the DEA on May 14,2014 by then Kentucky Agriculture Commissioner, now U.S. Congressional Representative James Comer.
“Over a decade ago, the Ninth Circuit held that non-psychoactive hemp is not controlled by the CSA,” saidPatrick Goggin, co-counsel for the HIA. “The DEA is again attempting to schedule under the CSAcannabinoids and non-psychoactive hemp beyond its authority. We believe the Ninth Circuit will invalidatethis rule just like it did in 2004.”
To date, 31 states have passed hemp legislation that allows their farmers to cultivate hemp according toguidelines set forth in the Farm Bill. Per these guidelines, U.S. farmers planted nearly 10,000 acres of hempin 2016. Farmers and agri-business across the country have invested many millions of dollars ininfrastructure to comply with federal law; this retroactive misreading of statute puts the livelihood of theselaw-abiding companies and individuals at risk.
Recent DEA pronouncements indicate that DEA is threatening to flout prior court rulings, and assertregulatory authority over hemp seed, oil, and products made from hemp seed and oil, which have alwaysbeen exempt from the Controlled Substances Act. HIA continues to monitor these developments, and willconsider further actions to resist DEA’s unlawful attempts to regulate legal hemp products.
# # #